1228
NEW ZEALAND GAZETTE
No. 60

Name and Strength
Amorolfine 0.25% as the hydrochloride
Polyethylene glycol 3350 59 g;
Sodium sulphate 5.685 g;
Sodium bicarbonate 1.685 g;
Sodium chloride 1.465 g;
Potassium chloride 0.7425 g
Nilutamide 50 mg, 100 mg
Paroxetine hydrochloride 20 mg, 30 mg

Form
cream
powder for reconstitution for oral administration
tablets
tablets

Name and Address of Manufacturer
F Hoffman-La Roche Limited, Basle, Switzerland
Birex Pharmaceuticals Limited, Blackrock, Co. Dublin, Ireland
Les Laboratoires Cassenne, Puteaux, France
Beecham Pharmaceuticals, Manor Royal, Crawley, Sussex, United Kingdom, or Les Laboratoires Beecham, Mayenne, France

Proprietary Name (if any)
Loceryl
Klean Prep
Anandron
Aropax

Dated this 25th day of April 1992.
C. LOVELACE, Director-General of Health.
Pursuant to delegation given by the Minister of Health on 5 June 1991.
go3992

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength
Mesalazine 1 gm
Benazepril hydrochloride 5 mg, 10 mg, 20 mg
Selegiline hydrochloride 5 mg
Selegiline hydrochloride 2 mg/ml

Form
suppository
tablets
tablets
mixture

Name and Address of Manufacturer
Ferring A/S, Vanlose, Denmark
Ciba-Geigy AG, Basle, Switzerland
Orion Corporation Pharmaceuticals, Turku, Finland
Orion Corporation Pharmaceuticals, Sanginsuu, Oulu, Finland

Proprietary Name (if any)
Pentasa
Cibacen
Eldepryl
Eldepryl

Dated this 25th day of April 1992.
C. LOVELACE, Director-General of Health.
Pursuant to delegation given by the Minister of Health on 5 June 1991.
go3990

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength
Midodrine hydrochloride 2.5 mg, 5 mg

Form
tablets

Name and Address of Manufacturer
Hafslund Nycomed Pharma AG, Linz, Austria

Proprietary Name (if any)
Gutron

Dated this 25th day of April 1992.
C. LOVELACE, Director-General of Health.
Pursuant to delegation given by the Minister of Health on 5 June 1991.
go3993

Psychologists Act 1981

Membership of Psychologists Board

Pursuant to section 3 (2) (d) of the Psychologists Act 1981, I hereby appoint

Victor Soeterik

to be a member of the Psychologists Board for a term of office expiring on the 23rd day of January 1995.

Dated at Wellington this 8th day of April 1992.

KATHERINE O'REGAN, Associate Minister of Health.
go3963

Internal Affairs

Local Government Act 1974

Report on the Severance Settlement Agreed Between the Wellington City Council and Mr Richard J. Nanson—Terms of Reference

The Minister of Local Government requests the Local Government Commission (under the provisions of section 37x (1) (b) of the Local Government Act 1974) to:

(a) Investigate and establish the full cost of the severance settlement agreed between The Wellington City Council and Mr Richard J. Nanson, including any other incidental costs incurred or likely to be incurred by the council in relation to that settlement; and